Arkolith/Insider Trading/ZBIO/Form 4/A

Xiao Ting

DirectorZenas BioPharma, Inc. (ZBIO) · full profile →Form 4/A · filed Apr 28, 2025
Net Buying
Open-Market Buys
$78K
Open-Market Sells
$0
Net Open-Market Flow
$78K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 7, 2025Buy(P)10K$7.76$78K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-25-039771) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML